Tax News Update    Email this document    Print this document  

February 17, 2023
2023-0323

Senate Commerce Committee hearing on pharmacy benefit managers

On February 16, the Senate Commerce, Science, & Transportation Committee held a hearing entitled, "Bringing Transparency and Accountability to Pharmacy Benefit Managers." The hearing centered on the bipartisan Pharmacy Benefit Manager Transparency Act (S. 127) reintroduced by Committee Chair Maria Cantwell (D-WA) and Sen. Chuck Grassley (R-IA). The bill would prohibit pharmacy benefit managers (PBMs) from charging health plans more for a drug than they reimburse to pharmacies (also known as "spread pricing") or imposing retroactive clawbacks on pharmacies and require PBMs to report certain information about payments they receive from health plans and fees charged to pharmacies to the Federal Trade Commission (FTC) on an annual basis.

During the hearing, both Democrats and Republicans cited a need for additional transparency to better understand how money flows through PBMs and the role PBMs play in patients' out-of-pocket drug costs. However, some Republicans, including Ranking Member Ted Cruz (R-TX), raised concerns about the bill's provisions related to the FTC and the potential for the FTC to assume new authorities at a time when there are no Republican commissioners.

The panel heard from two panels of witnesses. First, Sen. Grassley who twice assured Sen. Cruz that the bill would not give the FTC any new authority. They heard next from a panel of providers, including a pharmacist and an oncologist, and two economists. While most of the panelists spoke in favor of increasing PBM transparency, Casey Mulligan, a professor in economics at the University of Chicago, warned about the potential downfalls of increased PBM regulation.

More information is available here.

Additional information is also available in the attached Tax Alert.

———————————————

Contact Information
For additional information concerning this Alert, please contact:
 
Washington Council Ernst & Young
   • Heather Meade (heather.meade@ey.com)
   • Heather Bell (heather.bell@ey.com)

———————————————
ATTACHMENT

Senate hearing on pharmacy benefit managers

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement